Machine Learning for Discovery of GSK3β Inhibitors

Machine Learning for Discovery of GSK3β Inhibitors

Bibliographic Details
Main Authors:	Patricia A. Vignaux, Eni Minerali, Daniel H. Foil, Ana C. Puhl, Sean Ekins
Format:	Article
Language:	English
Published:	American Chemical Society 2020-10-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.0c03302

Similar Items

Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and Cancer
by: Ana C. Puhl, et al.
Published: (2024-02-01)

Machine Learning for Discovery of New ADORA Modulators
by: Ana C. Puhl, et al.
Published: (2022-06-01)

Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches
by: Rosa Buonfiglio, et al.
Published: (2020-05-01)

Correction to “Using Bibliometric Analysis and Machine Learning to Identify Compounds Binding to Sialidase-1”
by: Jennifer J. Klein, et al.
Published: (2021-06-01)

Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors
by: Jingyu Zhu, et al.
Published: (2020-09-01)

Discovery of GSK3β Inhibitors through In Silico Prediction-and-Experiment Cycling Strategy, and Biological Evaluation
by: Yuno Lee, et al.
Published: (2022-06-01)

Glycogen synthase kinase 3 (GSK-3) and its inhibitors : drug discovery and development /
by: Martinez, Ana, 1961-, et al.
Published: (2006)

Identification of New GSK3β Inhibitors through a Consensus Machine Learning-Based Virtual Screening
by: Salvatore Galati, et al.
Published: (2023-12-01)

Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity
by: Taha F. S. Ali, et al.
Published: (2022-03-01)

The inhibitors of cyclin-dependent kinases and GSK-3β enhance osteoclastogenesis
by: Yosuke Akiba, et al.
Published: (2016-03-01)

Novel reporter alleles of GSK-3α and GSK-3β.
by: William B Barrell, et al.
Published: (2012-01-01)

Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma
by: Kwanghee Ahn, et al.
Published: (2019-05-01)

Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles
by: Martin Nwadiugwu, et al.
Published: (2024-02-01)

Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease
by: Suggala Ramya Shri, et al.
Published: (2023-11-01)

Computational study of some cancer drugs as potent inhibitors of GSK3β
by: David Ebuka Arthur, et al.
Published: (2020-11-01)

The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells
by: Ata ur Rahman Mohammed Abdul, et al.
Published: (2018-01-01)

Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site
by: Ido Rippin, et al.
Published: (2020-11-01)

GSK-3β and Memory Formation
by: Akihiko eTakashima
Published: (2012-04-01)

GSK3β and the aging kidney
by: Jordan A. Kreidberg, et al.
Published: (2022-02-01)

Structural Plasticity of Dendritic Spines Requires GSK3α and GSK3β.
by: Iwona A Cymerman, et al.
Published: (2015-01-01)

GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation
by: Agata Gozdz, et al.
Published: (2017-06-01)

Opposing Roles of GSK3α and GSK3β Phosphorylation in Platelet Function and Thrombosis
by: Samantha F. Moore, et al.
Published: (2021-09-01)

Discovery of imidazole-based GSK-3β inhibitors for transdifferentiation of human mesenchymal stem cells to neurons: A potential single-molecule neurotherapeutic foresight
by: Varsha Gupta, et al.
Published: (2022-12-01)

Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity
by: Laura Llorach-Pares, et al.
Published: (2020-04-01)

Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection
by: Lynette Steele, et al.
Published: (2021-06-01)

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
by: Giuseppa Augello, et al.
Published: (2020-06-01)

Overexpression of GSK-3β in Adult Tet-OFF GSK-3β Transgenic Mice, and Not During Embryonic or Postnatal Development, Induces Tau Phosphorylation, Neurodegeneration and Learning Deficits
by: Alberto Rodríguez-Matellán, et al.
Published: (2020-09-01)

20(S)-protopanaxadiol promotes the migration, proliferation, and differentiation of neural stem cells by targeting GSK-3β in the Wnt/GSK-3β/β-catenin pathway
by: Kaili Lin, et al.
Published: (2020-05-01)

Glycogen synthase kinase-3β (GSK-3β) inhibitors from soil actinomycetes of Sabah rainforests : screening, purification and identification
by: Fauze Mahmud
Published: (2015)

GSK3β Inhibition Ameliorates Atherosclerotic Calcification
by: Xinjiang Cai, et al.
Published: (2023-07-01)

The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment
by: Anastasios Dimou, et al.
Published: (2020-07-01)

GSK3β inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury
by: Jian Weng, et al.
Published: (2018-01-01)

A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
by: L. Serenó, et al.
Published: (2009-09-01)

Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3
by: Paula Martínez de Iturrate, et al.
Published: (2020-01-01)

Computational Approaches to Identify Molecules Binding to Mycobacterium tuberculosis KasA
by: Ana C. Puhl, et al.
Published: (2020-11-01)

Targeting BRCA2 deficiency with GSK3 inhibitors
by: Zonderland, G
Published: (2017)

GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis
by: Sorin Hostiuc, et al.
Published: (2019-01-01)

1‑Sulfonyl-3-amino‑1H‑1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure–Activity Relationship
by: Elena Kazakova, et al.
Published: (2023-11-01)

Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models
by: Shuo Pang, et al.
Published: (2023-01-01)

Sensitization of glioma cells to tamoxifen-induced apoptosis by Pl3-kinase inhibitor through the GSK-3β/β-catenin signaling pathway.
by: Cuixian Li, et al.
Published: (2011-01-01)